• 25-Hydroxycholesterol-Induced AMPK Activation Shapes TAM Fun

  2026-08-04

  Xiao et al. (2024) reveal that 25-hydroxycholesterol (25HC) accumulates in tumor-associated macrophages (TAMs), driving lysosomal AMPK activation and metabolic reprogramming via a GPR155-mTORC1 pathway. This process enhances STAT6-dependent immunosuppressive functions, suggesting new therapeutic strategies for modulating macrophage activity in the tumor microenvironment.

• DAMGO and the Central Circuits of Opioid Tolerance: Translat

  2026-08-03

  This thought-leadership article explores the central mechanisms of opioid-induced hypersensitivity and tolerance, highlighting recent advances in opioid receptor signaling research. Leveraging DAMGO—a highly selective µ-opioid receptor agonist—as a model tool, we dissect the implications of brain-to-spinal opioid pathways for translational pain research. The discussion provides strategic guidance for researchers aiming to bridge mechanistic insights with effective chronic pain models and intervention strategies.

• Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea): From Herbi

  2026-08-03

  Explore the multifaceted applications of Diuron, a high-purity photosynthesis inhibitor, in advanced toxicology and predictive renal injury research. This article uncovers mechanistic insights and protocol parameters, offering researchers a deeper perspective on assay design and environmental risk.

• Sumatriptan Metabolism: Revisiting CYP and MAO Pathways

  2026-08-02

  This study redefines the metabolic fate of sumatriptan by demonstrating that cytochrome P450 enzymes, not just monoamine oxidase A, contribute to its N-demethylation. These findings challenge prevailing assumptions in neuropharmacology and have implications for drug design and neurodegenerative disease research.

• Tropifexor Enhances Intestinal Barrier in Parenteral Nutriti

  2026-08-01

  This study demonstrates that Tropifexor (LJN452), a potent FXR agonist, significantly mitigates parenteral nutrition-induced intestinal injury in neonatal piglets. Findings highlight the compound's role in restoring epithelial barrier integrity and modulating defense response genes, with translational implications for pediatric nutrition research.

• Bifendate (DDB): Mechanistic Leadership in Hepatoprotection

  2026-07-31

  Discover how Bifendate (DDB) transforms translational liver research by precisely modulating autophagy and lipid metabolism. This article provides mechanistic insight, strategic protocol guidance, and a forward-looking perspective for researchers aiming to bridge preclinical findings to impactful clinical solutions.

• Cy7 NHS Ester: Protocols for Near-Infrared Protein Labeling

  2026-07-31

  Cy7 NHS ester addresses challenges in protein and peptide labeling by offering a water-soluble, sulfonated near-infrared dye suitable for sensitive, low-background imaging. It is optimal for workflows requiring minimal organic co-solvents and rapid labeling but is not appropriate when long-term dye solutions or non-NIR wavelengths are necessary.

• Olaparib (AZD2281, Ku-0059436): Reliable Solutions for BRCA-

  2026-07-30

  This article addresses practical laboratory challenges in DNA damage response, tumor radiosensitization, and BRCA-associated cancer research, demonstrating how Olaparib (AZD2281, Ku-0059436) (SKU A4154) from APExBIO delivers reproducible, data-driven results. Scenario-driven Q&A blocks illustrate validated protocols, compatibility, and product selection strategies for maximizing assay reliability.

• Sulfo-Cy5 Carboxylic Acid: Versatile Fluorescent Dye for Lif

  2026-07-30

  Sulfo-Cy5 carboxylic acid stands out as a hydrophilic, high-sensitivity fluorescent dye for robust protein and peptide labeling, especially in aqueous environments. Its unique physicochemical properties minimize fluorescence quenching and streamline imaging workflows, making it an asset for advanced immunology and neuroscience research.

• GOT1 Inhibition by Ziprasidone Reprograms Glutamine Metaboli

  2026-07-29

  This study identifies ziprasidone as a potent non-competitive inhibitor of GOT1, disrupting glutamine metabolism and redox balance in pancreatic ductal adenocarcinoma (PDAC) cells. The findings highlight metabolic reprogramming via GOT1 inhibition as a promising strategy for suppressing tumor growth and underscore the importance of redox regulation in cancer biology.

• Carvedilol Beyond Cardioprotection: Mechanistic Insights for

  2026-07-29

  Explore the diverse applications of Carvedilol as a β-adrenergic receptor antagonist in advanced vascular and hematopoietic research. This article uncovers novel mechanistic insights and practical assay guidance, distinguishing itself from existing protocol and translational guides.

• Fulvestrant (ICI 182,780): Mechanistic Leverage and Translat

  2026-07-28

  This article unpacks the unique mechanistic profile and translational impact of Fulvestrant (ICI 182,780) in ER-positive breast cancer research. Integrating post-translational MDM2 regulation, apoptosis induction, and immune crosstalk insights, it delivers actionable guidance and strategic perspective for researchers tackling endocrine therapy resistance and chemotherapy sensitization, while positioning APExBIO’s Fulvestrant as an essential tool for advanced studies.

• Amphotericin B: Protocol Innovations for Fungal Infection Re

  2026-07-28

  Amphotericin B, a polyene antifungal antibiotic, is central to advanced fungal infection research due to its potent ergosterol-targeting mechanism. Recent breakthroughs reveal synergistic strategies and refined protocols that maximize efficacy while minimizing toxicity, empowering reproducible translational workflows.

• GS-441524 Prodrug Workflows: Applied Protocols & Troubleshoo

  2026-07-27

  GS-441524 is redefining antiviral research with robust, LC–MS/MS-enabled workflows and improved prodrug conversion strategies. This article unpacks experimental setups, stepwise protocols, and real-world troubleshooting to empower more reliable, translational SARS-CoV-2 inhibitor studies.

• TMEM16F in Kupffer Cells Restricts Listeria-Induced Liver In

  2026-07-27

  This study identifies TMEM16F expression in liver Kupffer cells as a critical factor limiting tissue damage and metabolic disruption during Listeria monocytogenes infection. By demonstrating cell-type-specific membrane repair and the regulation of inflammatory signaling, the research clarifies how host responses restrain excessive inflammation and offers new avenues for dissecting hepatic immune defense.

450 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page